<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>63</viewCount><searchCount>0</searchCount></scores><additional><submitter>Karlstaedt A</submitter><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><pagination>734364</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8631909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>Although metabolic remodeling during cardiovascular diseases has been well-recognized for decades, the recent development of analytical platforms and mathematical tools has driven the emergence of assessing cardiac metabolism using tracers. Metabolism is a critical component of cellular functions and adaptation to stress. The pathogenesis of cardiovascular disease involves metabolic adaptation to maintain cardiac contractile function even in advanced disease stages. Stable-isotope tracer measurements are a powerful tool for measuring flux distributions at the whole organism level and assessing metabolic changes at a systems level &lt;i>in vivo&lt;/i>. The goal of this review is to summarize techniques and concepts for &lt;i>in vivo&lt;/i> or &lt;i>ex vivo&lt;/i> stable isotope labeling in cardiovascular research, to highlight mathematical concepts and their limitations, to describe analytical methods at the tissue and single-cell level, and to discuss opportunities to leverage metabolic models to address important mechanistic questions relevant to all patients with cardiovascular disease.</pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pubmed_title>Stable Isotopes for Tracing Cardiac Metabolism in Diseases.</pubmed_title><pmcid>PMC8631909</pmcid><funding_grant_id>R00 HL141702</funding_grant_id><funding_grant_id>K99 HL141702</funding_grant_id><pubmed_authors>Karlstaedt A</pubmed_authors><view_count>63</view_count></additional><is_claimable>false</is_claimable><name>Stable Isotopes for Tracing Cardiac Metabolism in Diseases.</name><description>Although metabolic remodeling during cardiovascular diseases has been well-recognized for decades, the recent development of analytical platforms and mathematical tools has driven the emergence of assessing cardiac metabolism using tracers. Metabolism is a critical component of cellular functions and adaptation to stress. The pathogenesis of cardiovascular disease involves metabolic adaptation to maintain cardiac contractile function even in advanced disease stages. Stable-isotope tracer measurements are a powerful tool for measuring flux distributions at the whole organism level and assessing metabolic changes at a systems level &lt;i>in vivo&lt;/i>. The goal of this review is to summarize techniques and concepts for &lt;i>in vivo&lt;/i> or &lt;i>ex vivo&lt;/i> stable isotope labeling in cardiovascular research, to highlight mathematical concepts and their limitations, to describe analytical methods at the tissue and single-cell level, and to discuss opportunities to leverage metabolic models to address important mechanistic questions relevant to all patients with cardiovascular disease.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2024-12-04T13:04:55.207Z</modification><creation>2022-02-11T14:02:06.612Z</creation></dates><accession>S-EPMC8631909</accession><cross_references><pubmed>34859064</pubmed><doi>10.3389/fcvm.2021.734364</doi></cross_references></HashMap>